chr8-41714174-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000037.4(ANK1):​c.1782C>A​(p.Ser594Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0326 in 1,443,150 control chromosomes in the GnomAD database, including 955 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 68 hom., cov: 32)
Exomes 𝑓: 0.034 ( 887 hom. )

Consequence

ANK1
NM_000037.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.570

Publications

4 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 8-41714174-G-T is Benign according to our data. Variant chr8-41714174-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261294.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0229 (3482/152284) while in subpopulation NFE AF = 0.0361 (2454/68016). AF 95% confidence interval is 0.0349. There are 68 homozygotes in GnomAd4. There are 1587 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 68 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000037.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
NM_000037.4
MANE Select
c.1782C>Ap.Ser594Ser
synonymous
Exon 16 of 43NP_000028.3
ANK1
NM_001142446.2
c.1881C>Ap.Ser627Ser
synonymous
Exon 16 of 43NP_001135918.1P16157-21
ANK1
NM_020476.3
c.1782C>Ap.Ser594Ser
synonymous
Exon 16 of 42NP_065209.2P16157-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
ENST00000289734.13
TSL:1 MANE Select
c.1782C>Ap.Ser594Ser
synonymous
Exon 16 of 43ENSP00000289734.8P16157-3
ANK1
ENST00000265709.14
TSL:1
c.1881C>Ap.Ser627Ser
synonymous
Exon 16 of 43ENSP00000265709.8P16157-21
ANK1
ENST00000347528.8
TSL:1
c.1782C>Ap.Ser594Ser
synonymous
Exon 16 of 42ENSP00000339620.4P16157-1

Frequencies

GnomAD3 genomes
AF:
0.0229
AC:
3481
AN:
152168
Hom.:
68
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00675
Gnomad AMI
AF:
0.0209
Gnomad AMR
AF:
0.0304
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00476
Gnomad FIN
AF:
0.0137
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0361
Gnomad OTH
AF:
0.0268
GnomAD2 exomes
AF:
0.0221
AC:
3902
AN:
176364
AF XY:
0.0218
show subpopulations
Gnomad AFR exome
AF:
0.00554
Gnomad AMR exome
AF:
0.0197
Gnomad ASJ exome
AF:
0.00979
Gnomad EAS exome
AF:
0.000144
Gnomad FIN exome
AF:
0.0132
Gnomad NFE exome
AF:
0.0350
Gnomad OTH exome
AF:
0.0309
GnomAD4 exome
AF:
0.0337
AC:
43556
AN:
1290866
Hom.:
887
Cov.:
30
AF XY:
0.0330
AC XY:
20756
AN XY:
629494
show subpopulations
African (AFR)
AF:
0.00541
AC:
162
AN:
29956
American (AMR)
AF:
0.0222
AC:
755
AN:
34040
Ashkenazi Jewish (ASJ)
AF:
0.00956
AC:
188
AN:
19670
East Asian (EAS)
AF:
0.000111
AC:
4
AN:
35958
South Asian (SAS)
AF:
0.00508
AC:
278
AN:
54772
European-Finnish (FIN)
AF:
0.0156
AC:
723
AN:
46250
Middle Eastern (MID)
AF:
0.00378
AC:
18
AN:
4764
European-Non Finnish (NFE)
AF:
0.0394
AC:
39897
AN:
1013428
Other (OTH)
AF:
0.0294
AC:
1531
AN:
52028
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
2119
4238
6358
8477
10596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1610
3220
4830
6440
8050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0229
AC:
3482
AN:
152284
Hom.:
68
Cov.:
32
AF XY:
0.0213
AC XY:
1587
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00676
AC:
281
AN:
41572
American (AMR)
AF:
0.0303
AC:
464
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0107
AC:
37
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4826
European-Finnish (FIN)
AF:
0.0137
AC:
145
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0361
AC:
2454
AN:
68016
Other (OTH)
AF:
0.0265
AC:
56
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
165
331
496
662
827
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0252
Hom.:
28
Bravo
AF:
0.0238
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Hereditary spherocytosis type 1 (3)
-
-
2
not provided (2)
-
-
1
not specified (1)
-
-
1
Spherocytosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
9.0
DANN
Benign
0.70
PhyloP100
0.57
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=68/32
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61753679; hg19: chr8-41571692; COSMIC: COSV55888891; API